High-dose corticosteroid therapy in COVID-19: the RECOVERY trial - Authors' reply.
Peto L. et al, (2024), Lancet, 403, 1339 - 1340
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial.
RECOVERY Collaborative Group None., (2024), Lancet Child Adolesc Health, 8, 190 - 200
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
RECOVERY Collaborative Group None. et al, (2024), Nat Commun, 15
Molnupiravir or nirmatrelvir-ritonavir versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group None. et al, (2024)
Community involvement in an outbreak - One year on for mpox.
Cheyne A. et al, (2023), Clin Infect Dis
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
RECOVERY Collaborative Group None., (2023), Lancet Diabetes Endocrinol, 11, 905 - 914
Methylprednisolone, intravenous immunoglobulin, tocilizimab or anakinra for children with Paediatric Inflammatory Multisystem Syndrome temporally associated with SARS CoV-2 (PIMS-TS, MIS-C) – report from a randomised, controlled, open-label, platform trial
LANDRAY M. et al, (2023), Lancet Child and Adolescent Health
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
RECOVERY Collaborative Group. Electronic address: recoverytrial@ndph.ox.ac.uk None. and RECOVERY Collaborative Group None., (2023), Lancet, 401, 1499 - 1507
Randomised controlled trials for mpox in endemic countries.
Rojek A. et al, (2023), Lancet Infect Dis
Microbial diversity and antimicrobial resistance in faecal samples from acute medical patients assessed through metagenomic sequencing.
Yokoyama M. et al, (2023), PLoS One, 18
Virus Detection and Identification in Minutes Using Single-Particle Imaging and Deep Learning.
Shiaelis N. et al, (2022), ACS Nano
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
RECOVERY Collaborative Group None., (2022), Lancet, 400, 359 - 368
Establishing COVID-19 trials at scale and pace: Experience from the RECOVERY trial.
Peto L. et al, (2022), Adv Biol Regul